Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Weigert

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Nature Communications|September 23, 2022
Accumulation of mutations in antibody and CD8 T cell epitopes in a B cell depleted lymphoma patient with chronic SARS-CoV-2 infectionElham Khatamzas, Markus H Antwerpen, Alexandra Rehn, et al.
Cancer Discovery|January 10, 2020
Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in LymphomaPatrizia Mondello, Saber Tadros, Matt Teater, et al.
Leukemia|January 16, 2026
Strong constitutive NF-κB signaling in B cells drives SLL/CLL-like lymphomagenesis and overcomes microenvironmental dependenciesValeria Soberón, Lena Osswald, Andrew Moore, et al.
Leukemia|April 27, 2024
The addition of bortezomib to rituximab, high-dose cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma-a randomized, open-label phase III trial of the European mantle cell lymphoma networkLuca Fischer, Linmiao Jiang, Jan Dürig, et al.
Nature Medicine|December 9, 2014
Mutations in G protein β subunits promote transformation and kinase inhibitor resistanceAkinori Yoda, Guillaume Adelmant, Jerome Tamburini, et al.
The Journal of Experimental Medicine|January 25, 2012
Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibitionOliver Weigert, Andrew A Lane, Liat Bird, et al.
Leukemia|July 19, 2022
PARP14 is a novel target in STAT6 mutant follicular lymphomaMichael Mentz, William Keay, Carolin Dorothea Strobl, et al.
Blood Cancer Journal|August 7, 2024
Identification of genetic subtypes in follicular lymphomaVictoria Shelton, Rajesh Detroja, Ting Liu, et al.
Plos One|July 5, 2013
Gauging NOTCH1 Activation in Cancer Using ImmunohistochemistryMichael J Kluk, Todd Ashworth, Hongfang Wang, et al.
The Lancet. Oncology|August 11, 2015
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registryAlessandro Pastore, Vindi Jurinovic, Robert Kridel, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Nature Communications|September 23, 2022
Accumulation of mutations in antibody and CD8 T cell epitopes in a B cell depleted lymphoma patient with chronic SARS-CoV-2 infectionElham Khatamzas, Markus H Antwerpen, Alexandra Rehn, et al.
Cancer Discovery|January 10, 2020
Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in LymphomaPatrizia Mondello, Saber Tadros, Matt Teater, et al.
Leukemia|January 16, 2026
Strong constitutive NF-κB signaling in B cells drives SLL/CLL-like lymphomagenesis and overcomes microenvironmental dependenciesValeria Soberón, Lena Osswald, Andrew Moore, et al.
Leukemia|April 27, 2024
The addition of bortezomib to rituximab, high-dose cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma-a randomized, open-label phase III trial of the European mantle cell lymphoma networkLuca Fischer, Linmiao Jiang, Jan Dürig, et al.
Nature Medicine|December 9, 2014
Mutations in G protein β subunits promote transformation and kinase inhibitor resistanceAkinori Yoda, Guillaume Adelmant, Jerome Tamburini, et al.
The Journal of Experimental Medicine|January 25, 2012
Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibitionOliver Weigert, Andrew A Lane, Liat Bird, et al.
Leukemia|July 19, 2022
PARP14 is a novel target in STAT6 mutant follicular lymphomaMichael Mentz, William Keay, Carolin Dorothea Strobl, et al.
Blood Cancer Journal|August 7, 2024
Identification of genetic subtypes in follicular lymphomaVictoria Shelton, Rajesh Detroja, Ting Liu, et al.
Plos One|July 5, 2013
Gauging NOTCH1 Activation in Cancer Using ImmunohistochemistryMichael J Kluk, Todd Ashworth, Hongfang Wang, et al.
The Lancet. Oncology|August 11, 2015
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registryAlessandro Pastore, Vindi Jurinovic, Robert Kridel, et al.
Pageof 8